These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17061395)

  • 1. PET visualizes antitumor immune response.
    J Nucl Med; 2006 Jan; 47(1):20N, 22N. PubMed ID: 17061395
    [No Abstract]   [Full Text] [Related]  

  • 2. Visualization of a primary anti-tumor immune response by positron emission tomography.
    Shu CJ; Guo S; Kim YJ; Shelly SM; Nijagal A; Ray P; Gambhir SS; Radu CG; Witte ON
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17412-7. PubMed ID: 16293690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
    Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D
    J Virol; 1999 Mar; 73(3):2280-7. PubMed ID: 9971811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of bone marrow CD8 T lymphocytes confers full protection vs. tumor growth in M-MSV/MuLV experimental model.
    Facchinetti A; Biasi G
    Immunol Lett; 2012 May; 144(1-2):78-9. PubMed ID: 22465204
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.
    Schepers K; Toebes M; Sotthewes G; Vyth-Dreese FA; Dellemijn TA; Melief CJ; Ossendorp F; Schumacher TN
    J Immunol; 2002 Sep; 169(6):3191-9. PubMed ID: 12218137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures.
    Hirschman SZ; Fischinger PJ; O'Connor TE
    J Natl Cancer Inst; 1970 Jan; 44(1):107-16. PubMed ID: 11515020
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ; Koppi TA; McKenzie IF
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes caused in the homing patterns of chromium 51-labeled lymphoid cells by Moloney sarcoma virus infection.
    Gillette RW; Fox A
    J Natl Cancer Inst; 1977 Jun; 58(6):1621-8. PubMed ID: 864743
    [No Abstract]   [Full Text] [Related]  

  • 12. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scaffold protein Cybr is required for cytokine-modulated trafficking of leukocytes in vivo.
    Coppola V; Barrick CA; Bobisse S; Rodriguez-Galan MC; Pivetta M; Reynolds D; Howard OM; Palko ME; Esteban PF; Young HA; Rosato A; Tessarollo L
    Mol Cell Biol; 2006 Jul; 26(14):5249-58. PubMed ID: 16809763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on immunity to autochthonous mouse tumors.
    Hellström I; Hellström KE; Pierce GE; Fefer A
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.
    Law LW; Ting RC
    J Natl Cancer Inst; 1970 Mar; 44(3):615-21. PubMed ID: 11515430
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative imaging of the T cell antitumor response by positron-emission tomography.
    Dubey P; Su H; Adonai N; Du S; Rosato A; Braun J; Gambhir SS; Witte ON
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1232-7. PubMed ID: 12547911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
    Pazmiño NH; Yuhas JM
    Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
    Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor removal enhances immunity induced by B7.1.
    Lee MJ; Choi SH; Shim YH; Cho SH; Kim CW
    Pathobiology; 2001; 69(5):281-8. PubMed ID: 12107346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.